Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 283
6
Diseases
105
Unique genes
0.117
Avg. similarity score
Differentiated thyroid carcinoma
Most-connected disease (4 links)
Disease
Searched: Thyroid carcinoma
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Thyroid carcinoma
Differentiated thyroid carcinoma
Thyroid cancer
Toxic nodular goiter
Hurthle cell thyroid cancer
Multinodular goiter
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Differentiated thyroid carcinoma | 4 | 4 | 49 |
| Thyroid cancer | 3 | 3 | 34 |
| Thyroid carcinoma | 3 | 3 | 9 |
| Toxic nodular goiter | 3 | 3 | 17 |
| Hurthle cell thyroid cancer | 2 | 2 | 1 |
| Multinodular goiter | 1 | 1 | 28 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| MBIP | 4 / 6 | Differentiated thyroid carcinoma, Multinodular goiter, Thyroid cancer, Toxic nodular goiter |
| NRG1 | 4 / 6 | Differentiated thyroid carcinoma, Thyroid cancer, Thyroid carcinoma, Toxic nodular goiter |
| NDUFA13 | 3 / 6 | Differentiated thyroid carcinoma, Hurthle cell thyroid cancer, Thyroid carcinoma |
| NFIA | 3 / 6 | Differentiated thyroid carcinoma, Multinodular goiter, Toxic nodular goiter |
| PCNX2 | 3 / 6 | Differentiated thyroid carcinoma, Thyroid cancer, Thyroid carcinoma |
| SLK | 3 / 6 | Differentiated thyroid carcinoma, Thyroid cancer, Toxic nodular goiter |
| STN1 | 3 / 6 | Differentiated thyroid carcinoma, Thyroid cancer, Toxic nodular goiter |
| TERT | 3 / 6 | Differentiated thyroid carcinoma, Thyroid cancer, Toxic nodular goiter |
| TG | 3 / 6 | Multinodular goiter, Thyroid cancer, Toxic nodular goiter |
| TRMO | 3 / 6 | Differentiated thyroid carcinoma, Thyroid cancer, Thyroid carcinoma |
| BCAS3 | 2 / 6 | Multinodular goiter, Toxic nodular goiter |
| FAM227B | 2 / 6 | Multinodular goiter, Toxic nodular goiter |
| FGF7 | 2 / 6 | Multinodular goiter, Toxic nodular goiter |
| FOXE1 | 2 / 6 | Differentiated thyroid carcinoma, Thyroid cancer |
| INSR | 2 / 6 | Multinodular goiter, Toxic nodular goiter |
| ITPK1 | 2 / 6 | Multinodular goiter, Toxic nodular goiter |
| MICOS10 | 2 / 6 | Multinodular goiter, Toxic nodular goiter |
| PRDM11 | 2 / 6 | Multinodular goiter, Toxic nodular goiter |
| SEPTIN11 | 2 / 6 | Differentiated thyroid carcinoma, Thyroid carcinoma |
| SOWAHB | 2 / 6 | Differentiated thyroid carcinoma, Thyroid carcinoma |
| VAV3 | 2 / 6 | Differentiated thyroid carcinoma, Thyroid carcinoma |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Thyroid cancer | KEGG | 12 / 37 | 37.1× | 1.62e-16 | 6.45e-14 ✓ sig. |
| FoxO signaling pathway | KEGG | 11 / 133 | 9.5× | 2.08e-8 | 1.57e-6 ✓ sig. |
| Pathways in cancer | KEGG | 19 / 533 | 4.1× | 1.50e-7 | 9.00e-6 ✓ sig. |
| RAS GTPase cycle mutants | Reactome | 3 / 3 | 114× | 6.49e-7 | 3.21e-5 ✓ sig. |
| Chronic myeloid leukemia | KEGG | 7 / 77 | 10.4× | 4.65e-6 | 1.73e-4 ✓ sig. |
| SHC1 events in ERBB4 signaling | Reactome | 4 / 14 | 32.7× | 5.16e-6 | 1.89e-4 ✓ sig. |
| GRB2 events in ERBB2 signaling | Reactome | 4 / 14 | 32.7× | 5.16e-6 | 1.89e-4 ✓ sig. |
| Activation of RAS in B cells | Reactome | 3 / 5 | 68.6× | 6.41e-6 | 2.23e-4 ✓ sig. |
| Estrogen-stimulated signaling through PRKCZ | Reactome | 3 / 6 | 57.2× | 1.27e-5 | 4.00e-4 ✓ sig. |
| Longevity regulating pathway | KEGG | 7 / 90 | 8.9× | 1.32e-5 | 4.10e-4 ✓ sig. |
| Longevity regulating pathway - multiple species | KEGG | 6 / 62 | 11.1× | 1.60e-5 | 4.83e-4 ✓ sig. |
| RAS signaling downstream of NF1 loss-of-function variants | Reactome | 3 / 7 | 49.0× | 2.22e-5 | 6.35e-4 ✓ sig. |
| FLT3 Signaling | Reactome | 3 / 7 | 49.0× | 2.22e-5 | 6.35e-4 ✓ sig. |
| Central carbon metabolism in cancer | KEGG | 6 / 71 | 9.7× | 3.50e-5 | 9.27e-4 ✓ sig. |
| p38MAPK events | Reactome | 3 / 8 | 42.9× | 3.52e-5 | 9.33e-4 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| thyroid gland development | GO:0030878 | 6 / 30 | 35.6× | 1.45e-8 | 2.34e-6 ✓ sig. |
| cell surface receptor protein tyrosine kinase signaling pathway | GO:0007169 | 7 / 120 | 10.4× | 5.11e-6 | 3.08e-4 ✓ sig. |
| positive regulation of gene expression | GO:0010628 | 12 / 504 | 4.2× | 2.61e-5 | 1.10e-3 ✓ sig. |
| positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001241 | 3 / 11 | 48.5× | 2.75e-5 | 1.15e-3 ✓ sig. |
| positive regulation of DNA-templated transcription | GO:0045893 | 15 / 778 | 3.4× | 2.90e-5 | 1.20e-3 ✓ sig. |
| substantia propria of cornea development | GO:1903701 | 2 / 2 | 178× | 3.13e-5 | 1.26e-3 ✓ sig. |
| telomere capping | GO:0016233 | 3 / 12 | 44.5× | 3.66e-5 | 1.43e-3 ✓ sig. |
| neuron development | GO:0048666 | 5 / 77 | 11.6× | 7.29e-5 | 2.39e-3 ✓ sig. |
| telomere assembly | GO:0032202 | 2 / 3 | 119× | 9.35e-5 | 2.88e-3 ✓ sig. |
| cellular response to estrogen stimulus | GO:0071391 | 3 / 19 | 28.1× | 1.56e-4 | 4.24e-3 ✓ sig. |
| MAPK cascade | GO:0000165 | 6 / 147 | 7.3× | 1.82e-4 | 4.73e-3 ✓ sig. |
| regulation of transforming growth factor beta2 production | GO:0032909 | 2 / 4 | 89.0× | 1.86e-4 | 4.81e-3 ✓ sig. |
| response to isolation stress | GO:0035900 | 2 / 4 | 89.0× | 1.86e-4 | 4.81e-3 ✓ sig. |
| positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | GO:0051897 | 7 / 217 | 5.7× | 2.25e-4 | 5.46e-3 ✓ sig. |
| negative regulation of telomere maintenance via telomerase | GO:0032211 | 3 / 22 | 24.3× | 2.46e-4 | 5.84e-3 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Multinodular goiter | Toxic nodular goiter | 0.278 | 10 | 1.23e-24 | 2.93e-23 ✓ sig. |
| Differentiated thyroid carcinoma | Thyroid carcinoma | 0.135 | 7 | 7.57e-17 | 1.22e-15 ✓ sig. |
| Differentiated thyroid carcinoma | Thyroid cancer | 0.105 | 8 | 9.84e-14 | 1.27e-12 ✓ sig. |
| Thyroid cancer | Toxic nodular goiter | 0.130 | 6 | 8.85e-13 | 1.07e-11 ✓ sig. |
| Differentiated thyroid carcinoma | Toxic nodular goiter | 0.098 | 6 | 9.11e-12 | 1.00e-10 ✓ sig. |
| Thyroid cancer | Thyroid carcinoma | 0.073 | 3 | 8.19e-7 | 4.87e-6 ✓ sig. |
| Hurthle cell thyroid cancer | Thyroid carcinoma | 0.100 | 1 | 5.84e-4 | 1.16e-3 ✓ sig. |
| Differentiated thyroid carcinoma | Hurthle cell thyroid cancer | 0.020 | 1 | 3.18e-3 | 4.17e-3 ✓ sig. |